Advertisement

Topics

FDA Approves Inotuzumab Ozogamicin (Besponsa) for ALL

12:10 EDT 17 Aug 2017 | Medscape

The new drug is for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). These patients have a very poor prognosis.
FDA Approvals

Original Article: FDA Approves Inotuzumab Ozogamicin (Besponsa) for ALL

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Inotuzumab Ozogamicin (Besponsa) for ALL"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...